Wegovy Coverage Under National Health Insurance? Obesity Drug Under Fire for Vision Loss Side Effects

[News Hunters]

When quoting or reporting from this interview, please explicitly credit the program name, SBS "News Hunters." Copyrights belong to SBS.

■ Broadcast: SBS "News Hunters" (Monday to Friday, 18:50 – 19:50)
■ Anchors: Kim Jong-won, Yoon Tae-jin
■ Guests: Lee Joo-yul (Professor, Department of Health Administration, Namseoul University), Cho Dong-chan (Distinguished Adjunct Professor, Department of Convergence Medicine, Hanyang University) 
--------------------------------------------
Amid the soaring popularity of obesity treatments like Wegovy and Mounjaro, Wegovy's manufacturer, Novo Nordisk, has applied for national health insurance coverage for the drug. While expectations are rising that prices will drop, concerns are being raised over whether it is appropriate to use already strained health insurance funds for obesity treatments. What are your thoughts on pushing for national health insurance coverage for Wegovy?

※ More details are available in the video.
※ Please note: This article was translated by AI and may contain errors.